Post-marketing safety surveillance conducted in Korea (2008-2013) following the introduction of the rotavirus vaccine, RIX4414 (Rotarix™)

MLA

Chun Soo Kim, et al. “Post-Marketing Safety Surveillance Conducted in Korea (2008-2013) Following the Introduction of the Rotavirus Vaccine, RIX4414 (Rotarix™).” Human Vaccinesimmunotherapeutics, vol. 12, no. 10, Aug. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b1b746dd8687b0c986bb2e6cd9b673d1&authtype=sso&custid=ns315887.

APA

Chun Soo Kim, Htay Htay Han, Aixue Liu, Girish Jayadeva, Son Moon Shin, & Naveen Karkada. (2016). Post-marketing safety surveillance conducted in Korea (2008-2013) following the introduction of the rotavirus vaccine, RIX4414 (Rotarix™). Human Vaccinesimmunotherapeutics, 12(10).

Chicago

Chun Soo Kim, Htay Htay Han, Aixue Liu, Girish Jayadeva, Son Moon Shin, and Naveen Karkada. 2016. “Post-Marketing Safety Surveillance Conducted in Korea (2008-2013) Following the Introduction of the Rotavirus Vaccine, RIX4414 (Rotarix™).” Human Vaccinesimmunotherapeutics 12 (10). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b1b746dd8687b0c986bb2e6cd9b673d1&authtype=sso&custid=ns315887.